EXPORT CITATION

Chapter-23 Episcleritis and Scleritis

BOOK TITLE: Gems of Ophthalmology—Cornea and Sclera

Author
1. Biswas Jyotirmay
2. Majumder Parthopratim Dutta
ISBN
9789352702480
DOI
10.5005/jp/books/18039_24
Edition
1/e
Publishing Year
2018
Pages
18
Author Affiliations
1. Sankara Nethralaya, Medical and Vision Research Foundation, Chennai, India, Sankara Nethralaya, Chennai, Tamil Nadu, India, Medical and Vision Research Foundation Sankara Nethralaya, 18, College Road Chennai, India, Medical and Vision Research Foundations, Chennai, Tamil Nadu, India, Medical and Vision Research Foundation, Shankara Nethralaya, Chennai, Sankara Nethralaya, Chennai, India, Medical Research Foundation, Sankara Nethralaya, Chennai, India, Sankara, Nethralaya, Chennai, Tamil Nadu, India, Sankara Nethralaya, A Unit of Medical Research Foundation, Nungambakkam, Chennai, Tamil Nadu, India, Sankara Nethralaya, Chennai, Tamil Nadu, Ind
2. Medical and Vision Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India, Sankara Nethralaya, Chennai, Tamil Nadu, India
Chapter keywords
Episcleritis, scleritis, acute red eye, optic nerve, sclera, nonsteroidal anti-inflammatory drug, NSAID, cyclooxygenase, nodular scleritis

Abstract

Episcleritis and scleritis are important causes of acute red eye. Even though both are inflammation of the outer coat of the eyeball, they are clinically, etiologically and morphologically distinct and different. Sclera is an opaque, elastic and resilient tissue of the eye. It can be compared with an incomplete shell comprising approximately 90% (five-sixths) of the outer coat of the eye. Anteriorly it begins at the limbus and terminates at the optic nerve canal posteriorly. It is predominantly composed of collagen and some elastin fibrils and is relatively avascular and acellular. This chapter covers the nomenclature and classification, diagnosis, diagnostic evaluation of scleritis, treatment, and surgical treatment. Diagnosis of scleritis is almost always clinical; however, when the posterior sclera is involved, clinical signs may be less obvious, and imaging studies are necessary to confirm the diagnosis. The primary aim of the treatment of scleral inflammation is to control the inflammatory process to relieve the symptoms and thereby reduce the damage to the eye.

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved